Acurx Pharmaceuticals
ACXP | NASDAQ
$0.94
-$0.02 (-2.08%)
At close: Nov 16, 2026, 4:00 PM ET
$1.04
+$0.10 (+10.64%)
After-hours:
Nov 16, 2026, 7:36 PM ET
-2.08%
(1D)No price chart data available for 1D timeframe.
Rating
35.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #637/1021 (Top 62%)
Key Statistics
Market Data
Market Cap $5.66M
1D Range
0.92 1.01
52W Range
0.92 6.63
Valuation (TTM)
PE -0.33
PB 0.00
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $11.00
Cash Flow
FCF Yield -119.9%
SBC Adj. FCF Yield -135.8%
SBC Impact -13.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 86.2% |
35.4%
FCF 3Y | 5Y 30.8% |
0.9%
Returns
ROA -0.1%
ROE -116.6%
ROIC -0.1%
Financial Health
Net Cash
$9.65B
Current Ratio 3.23
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate i...
Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Jun 25, 2021
Website www.acurxpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$11.00
Upside
+1070.21%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ACXP